70 related articles for article (PubMed ID: 38336701)
1. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor-based combination therapy.
Wei L; Li Z; Guo S; Ma H; Shi Y; An X; Huang K; Xiong L; Xue T; Zhang Z; Yao K; Luo J; Han H
Cancer; 2024 May; 130(9):1650-1662. PubMed ID: 38157276
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer with double heterozygosity for the
Shao B; Di L
Oncol Lett; 2024 Jun; 27(6):253. PubMed ID: 38646498
[TBL] [Abstract][Full Text] [Related]
3. SPP1 is associated with adverse prognosis and predicts immunotherapy efficacy in penile cancer.
Zou Y; Tan X; Yuan G; Tang Y; Wang Y; Yang C; Luo S; Wu Z; Yao K
Hum Genomics; 2023 Dec; 17(1):116. PubMed ID: 38111044
[TBL] [Abstract][Full Text] [Related]
4. Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic
Schwartzberg LS; Kiedrowski LA
Ther Adv Med Oncol; 2021; 13():17588359211006962. PubMed ID: 33868464
[TBL] [Abstract][Full Text] [Related]
5. A Targeted, Personalized Management Strategy in Advanced Penile Squamous Cell Carcinoma.
Holland LC; Gerald TS; Brooks B; Margulis V
Urology; 2024 Feb; 184():71-74. PubMed ID: 38056508
[TBL] [Abstract][Full Text] [Related]
6. Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies.
Safa H; Mercinelli C; Spiess PE; Necchi A; Chahoud J
Expert Opin Pharmacother; 2024 Mar; 25(4):447-465. PubMed ID: 38549550
[TBL] [Abstract][Full Text] [Related]
7. Effective combinatorial immunotherapy for penile squamous cell carcinoma.
Huang T; Cheng X; Chahoud J; Sarhan A; Tamboli P; Rao P; Guo M; Manyam G; Zhang L; Xiang Y; Han L; Shang X; Deng P; Luo Y; Lu X; Feng S; Ferrer MM; Alan Wang Y; DePinho RA; Pettaway CA; Lu X
Nat Commun; 2020 May; 11(1):2124. PubMed ID: 32358507
[TBL] [Abstract][Full Text] [Related]
8. Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report.
Peng S; Huang H; Zhu X; Chen J; Ding X; Wang F; Chen L; Lu Z
Exp Ther Med; 2024 May; 27(5):178. PubMed ID: 38515651
[TBL] [Abstract][Full Text] [Related]
9. CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.
Feber A; Worth DC; Chakravarthy A; de Winter P; Shah K; Arya M; Saqib M; Nigam R; Malone PR; Tan WS; Rodney S; Freeman A; Jameson C; Wilson GA; Powles T; Beck S; Fenton T; Sharp TV; Muneer A; Kelly JD
Cancer Res; 2016 Aug; 76(16):4720-4727. PubMed ID: 27325650
[TBL] [Abstract][Full Text] [Related]
10. Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report.
Zhang X; Xu Q; Zhang Y
Thorac Cancer; 2024 Mar; 15(8):667-671. PubMed ID: 38323364
[TBL] [Abstract][Full Text] [Related]
11. Severe hypercalcaemia in metastatic prostate cancer with biallelic BRCA2 mutations and lytic bone lesions.
Lazzari L; Ledet E; Hawkins M; Sartor O
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37562861
[TBL] [Abstract][Full Text] [Related]
12. BRCA2-positive lung adenocarcinoma treated with olaparib: A case report.
Motohashi T; Isobe K; Yoshizawa T; Usui Y; Shimizu H; Sekiya M; Miyoshi S; Nakamura Y; Urabe N; Sakamoto S; Homma S; Sadamoto S; Tochigi N; Kishi K
Respirol Case Rep; 2024 Mar; 12(3):e01317. PubMed ID: 38455501
[TBL] [Abstract][Full Text] [Related]
13. Niraparib for the Treatment of Metastatic NSCLC in a Patient With BRCA2 Germinal Mutation: A Case Report.
Inno A; Picece V; Bogina G; Settanni G; Viassolo V; Salgarello M; Gori S
Clin Lung Cancer; 2024 Mar; 25(2):175-179. PubMed ID: 38008640
[No Abstract] [Full Text] [Related]
14. Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a
Grossman JE; Wu Y; Ye H; Bhatt RS
JCO Precis Oncol; 2018; 2():. PubMed ID: 32914001
[No Abstract] [Full Text] [Related]
15. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
17. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.
Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G
J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913
[TBL] [Abstract][Full Text] [Related]
18. Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
Necchi A; Spiess PE; Costa de Padua T; Li R; Grivas P; Huang RSP; Lin DI; Danziger N; Ross JS; Jacob JM; Sager RA; Basnet A; Li G; Graf RP; Pavlick DC; Bratslavsky G
JAMA Netw Open; 2023 Dec; 6(12):e2348002. PubMed ID: 38150257
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
